Objective To evaluate the diagnostic and prognostic validity of determination serum AFP, CEA, CA50, CA19.9 and CA125 in patients with ovary malignant neoplasm.
CA19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis (a) antigen) is a tumor marker that is used primarily in the management of pancreatic cancer.